A failed trial for a heart drug casts shadow over rivals developing similar therapies

The full data from the closely watched clinical trial showed that the drug had no cardiovascular benefit even though it reduced Lp(a) levels.

Read the full story at MarketWatch

Shared from the GodsView world desk: live wires next to a globe of flights, ships, fires, and quakes.